Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
16.86 PLN | +1.20% | -2.66% | -7.11% |
May. 14 | Mabion S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 16 | Mabion S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 244
Sales per Business
PLN in Million | 2022 | Weight | Delta |
---|---|---|---|
Biological Drugs
100.0
%
| 164 | 100.0 % | - |
Sales per region
PLN in Million | 2022 | Weight | Delta |
---|---|---|---|
Poland
100.0
%
| 164 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Director of Finance/CFO | 50 | 18-12-31 | |
Slawomir Jaros
CTO | Chief Tech/Sci/R&D Officer | - | 09-10-28 |
Comptroller/Controller/Auditor | - | - | |
Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Chairman | 58 | 17-06-13 | |
Director/Board Member | 51 | - | |
Corporate Officer/Principal | - | - | |
Slawomir Kosciak
BRD | Director/Board Member | 40 | 21-02-22 |
David John James
BRD | Director/Board Member | - | - |
Wojciech Wosko
BRD | Director/Board Member | - | 21-02-22 |
Zofia Szewczuk
BRD | Director/Board Member | - | 21-08-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 16,162,326 | 10,295,878 ( 63.70 %) | 0 | 63.70 % |
Company contact information
Mabion SA
ul. gen. Mariana Langiewicza 60
95-050, Konstantynów Lódzki
+48 42 207 7890
http://www.mabion.euSector
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-7.11% | 68.33M | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-1.37% | 21.96B | |
-6.73% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- MAB Stock
- Company Mabion S.A.